250 Participants Needed

Provider Training Methods for Fetal Alcohol Spectrum Disorders

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Rochester
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests new methods for training mental health providers to identify and support children with fetal alcohol spectrum disorders (FASD). It compares two training approaches: group tele-mentoring sessions (ECHO implementation) and self-guided online materials (Self-Directed Learning implementation). The study aims to determine which method better equips providers to screen for prenatal alcohol exposure and support families. Licensed mental health providers in the U.S. who work with children aged 3 to 12 and have internet access are ideal candidates for this trial. As an unphased trial, it offers a unique opportunity to contribute to innovative training methods that could significantly enhance support for children with FASD.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that these training methods are safe for mental health providers?

Research has shown that the ECHO tele-mentoring approach effectively helps healthcare providers better diagnose fetal alcohol spectrum disorders (FASD). Participants find the training both effective and well-received.

The FMF Connect Pro is a mobile app designed for caregivers of children with FASD. Early research suggests users find it easy to use and helpful. No specific safety concerns have been reported, indicating the app is generally safe.

The self-directed learning method involves using the FMF Connect Pro app and similar resources independently. While specific safety data for this method is lacking, the app itself is considered safe for caregivers.

Overall, no known safety issues exist with the training methods being tested. Both ECHO and FMF Connect Pro have demonstrated positive results in improving healthcare providers' knowledge and skills.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative ways to train mental health providers in managing fetal alcohol spectrum disorders (FASD). Unlike traditional methods that may rely heavily on in-person training sessions, this trial investigates the effectiveness of ECHO tele-mentoring and self-directed learning. ECHO tele-mentoring enables providers to receive real-time guidance and share experiences in a collaborative setting, while self-directed learning offers flexibility by allowing providers to access training materials anytime. These methods aim to improve the screening, diagnosis, and support systems for FASD, potentially leading to better outcomes for affected individuals and their families.

What evidence suggests that this trial's training methods could be effective for FASD?

This trial will compare different training methods for healthcare providers in diagnosing and managing fetal alcohol spectrum disorders (FASD). Research has shown that the ECHO tele-mentoring approach, one of the methods under study, can enhance healthcare providers' ability to diagnose FASD in various regions. This method involves virtual sessions where experts teach providers, improving their skills in identifying and managing FASD. Another method tested in this trial is the FMF Connect Pro app, which studies have found useful and practical for caregivers of children with FASD. This app helps mental health providers learn to check for prenatal alcohol exposure and diagnose FASD. The trial also includes a self-directed learning approach, allowing providers to access similar information online at their own pace, offering more flexibility. Both methods aim to improve providers' knowledge and effectiveness in supporting families dealing with FASD.12678

Are You a Good Fit for This Trial?

This trial is for mental health providers in the U.S. who work with children aged 3 to 12 or their families, are fluent in English, and have internet access. It's not for those working outside the U.S. or who don't serve this age group.

Inclusion Criteria

Provides services in the United States
Fluency in English
Licensed mental health provider or supervised trainee
See 3 more

Exclusion Criteria

Provides services outside of the United States
Does not provide mental health services to children ages 3 to 12

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

3 months

Training

Mental health providers are trained in FMF Connect Pro using either ECHO tele-mentoring or self-directed materials

6 months
13 sessions (bi-weekly for ECHO group)

Follow-up

Participants are monitored for changes in FASD-informed practice and effectiveness of the training

6 months
Online assessments at 6 months and 12 months

Waitlist Implementation

Waitlist group receives FMF Connect Pro via self-directed materials after 6-month assessments

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • ECHO implementation
  • FMF Connect Pro
  • Self-Directed Learning implementation
Trial Overview The study tests 'FMF Connect Pro,' a tool helping providers screen for prenatal alcohol exposure and diagnose FASD. Providers will compare two training methods: a tele-mentoring ECHO approach and self-directed learning, against a waitlist control.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: FMF (Families Moving Forward) Connect Pro with Self-directed materialsExperimental Treatment2 Interventions
Group II: FMF (Families Moving Forward) Connect Pro with ECHO implementationExperimental Treatment2 Interventions
Group III: Waitlist Comparison GroupActive Control1 Intervention

ECHO implementation is already approved in United States for the following indications:

🇺🇸
Approved in United States as ECHO implementation for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Rochester

Lead Sponsor

Trials
883
Recruited
555,000+

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials
865
Recruited
1,091,000+

Published Research Related to This Trial

Fetal alcohol spectrum disorder (FASD) is a common but often misdiagnosed condition at birth, leading to inadequate care and support for affected children and their families.
Proper diagnosis of FASD is crucial for providing effective treatment and prevention opportunities, highlighting the need for structured interdisciplinary approaches in education and prevention efforts regarding alcohol consumption during pregnancy.
[Fetal alcohol spectrum disorders-diagnosis, prognosis, and prevention].Moder, JE., Ordenewitz, LK., Schlüter, JA., et al.[2021]
A 12-month community intervention involving 19 young women with Fetal Alcohol Spectrum Disorders (FASD) led to significant improvements in their lives, including reduced substance use and increased access to healthcare services.
The intervention's success was attributed to targeted education and collaboration with service providers, along with the support of paraprofessional advocate case managers, highlighting the importance of community-based approaches in addressing FASD.
A pilot community intervention for young women with fetal alcohol spectrum disorders.Grant, T., Huggins, J., Connor, P., et al.[2019]
The FMF Connect app, designed to support caregivers of children with fetal alcohol spectrum disorders (FASD), was found to be feasible and acceptable, with 84% of caregivers and 94% of providers successfully installing the app during beta testing with 45 participants.
Caregivers engaged positively with the app, averaging 20 minutes of use per session, primarily benefiting from the Learning Modules, which provided valuable information and practical support, while also highlighting areas for technical improvement.
Initial Feasibility of the "Families Moving Forward Connect" Mobile Health Intervention for Caregivers of Children With Fetal Alcohol Spectrum Disorders: Mixed Method Evaluation Within a Systematic User-Centered Design Approach.Petrenko, CLM., Kautz-Turnbull, CC., Roth, AR., et al.[2022]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38054571/
Tele-mentoring program to increase healthcare capacity for ...Conclusions: ECHO FASD is a feasible training method that shows promise in increasing diagnostic capacity across many geographic regions.
Extension for Community Healthcare Outcomes fetal alcohol ...Conclusions: ECHO FASD is a feasible training method that shows promise in increas- ing diagnostic capacity across many geographic regions. KEYWORDS.
Leveraging Technology to Increase Quality of Life for FASD ...We hypothesize mental health providers trained in Provider-Assisted FMF Connect through ECHO tele-mentoring will evidence greater practice change compared to ...
Provider Training Methods for Fetal Alcohol Spectrum ...The first training method involves 13-sessions of tele-mentoring using an Extension of Community Healthcare Outcomes (ECHO) approach. The second training method ...
Fetal Alcohol Spectrum Disorders Research StudiesThis study aims to develop and test a new intervention called “Thrive” for young adults with fetal alcohol spectrum disorders (FASD).
Fetal alcohol spectrum disorders prevention and clinical ...In a third project, her team is creating a tool, based on Extension of Community Healthcare Outcomes (ECHO) approaches, to train providers to ...
From surviving to thriving: A new conceptual model ...The “From Surviving to Thriving Model” proposes a paradigm shift, emphasizing personal strengths and quality of life to allow people with FASD to thrive.
Collaborative Initiative on Fetal Alcohol Spectrum DisordersCIFASD is a multidisciplinary, international consortium of research projects and resources charged with improving prevention, diagnosis, and treatment of FASD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security